Metagenomi Therapeutics (MGX) Other Non Operating Income (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Other Non Operating Income of -$1000.0 for Q1 2026, up 87.5% year-over-year from -$533.33 in Q1 2025, and up 90.91% quarter-over-quarter from -$11000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Other Non Operating Income (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$1000.0, up 87.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$84000.0 (up 49.09% YoY), and the FY2025 annual result was -$91000.0, up 56.04% from the prior year.
- Other Non Operating Income advanced to -$1000.0 in Q1 2026 per MGX's latest filing, from -$11000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $16000.0 in Q2 2023 and troughed at -$85000.0 in Q3 2023.
- A 4-year average of -$28692.3 and a median of -$11000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 4900.0% in 2024, then surged 96.49% in 2025.
- A 4-year view of Other Non Operating Income shows it stood at -$4000.0 in 2023, then sank by 1125.0% to -$49000.0 in 2024, then surged by 77.55% to -$11000.0 in 2025, then soared by 90.91% to -$1000.0 in 2026.
- Business Quant data shows MGX's Other Non Operating Income at -$1000.0 in Q1 2026, -$11000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Metagenomi Therapeutics | 46.60 Mn | 46.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -49,000.00 |
| Sep 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | -50,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | -85,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | -1,000.00 |